List Your Business
Skip to content
BREAKING
ADVERTISEMENT

WSA Q3 FY2025/26: 3% Growth, Signia MaX & Widex Allure AI

WS Audiology reports 3% organic growth in Q3 FY2025/26 with 8% consumer channel gains. See what Signia MaX and Widex Allure AI mean for buyers.

WSA Q3 FY2025/26: 3% Growth, Signia MaX & Widex Allure AI
Key Points
  • WS Audiology (WSA), parent company of Widex, Signia and Rexton, posted 3% organic revenue growth in Q3 of fiscal year 2025/26.
  • Quarterly revenue was €624 million (about US$729 million). Reported growth was only 1% because currency swings cut €12 million.
  • Consumer-facing channels (online, retail and managed care) grew 8%, while wholesale fell 2%.
  • EBITDA before special items rose 12% to €119 million, and the margin improved to 19.1%.
  • Net profit rose to €24 million from €20 million a year earlier.
  • Net debt is still high at €2.85 billion, but leverage and interest costs are slowly falling.

WS Audiology Q3 Results: A Stronger Quarter Powered by AI Hearing Aids

WS Audiology (WSA), the Danish group behind Widex, Signia and Rexton, has closed its third quarter of fiscal 2025/26 with firmer growth and better profits. The numbers show where the hearing aid industry is heading: AI-driven devices, stronger clinic and online sales channels, and tougher competition among manufacturers. If you are thinking about buying a hearing aid in India, these trends will shape the choices on offer in the coming years.

Third-Quarter Results at a Glance

For the three months ending June 30, WSA booked revenue of €624 million, roughly US$729 million. Organic growth, which strips out currency movements, came in at 3%. Reported growth was just 1%, because a weaker US dollar and Japanese yen against the euro shaved about €12 million off the total.

That is a clear improvement on the previous quarter, when organic growth was only 1%. Over the first nine months of the financial year, revenue reached about €1.881 billion (around US$2.20 billion). That is up 1% organically, although the reported figure fell 4%, mostly because of exchange rates. Management said the quarter matched its expectations and that momentum built toward the end of the period.

Why Organic Growth Matters

Organic growth is the number analysts watch most closely. It shows how much a business is really expanding through sales, without the distortion of currency changes or acquisitions. A move from 1% to 3% in one quarter suggests WSA’s core business is gaining traction, even while exchange rates drag on the headline figure.

Consumer-Facing Channels Lead the Way

The strongest performer was WSA’s consumer-facing division, which combines online sales, company-owned retail clinics and managed care programmes. Together these channels grew 8% organically.

ADVERTISEMENT

Managed care did much of the heavy lifting. It benefited from a rising number of insured people covered under these plans and from improved hearing benefits. Retail and online sales also contributed steady gains.

This matters because these channels bring a manufacturer closer to the end user. Selling directly through its own clinics and digital storefronts gives a company more control over pricing, service quality and the patient journey.

Wholesale Slows Down

The wholesale business, where WSA supplies hearing aids to independent clinics and distributors, shrank 2% organically. The company pointed to two causes: softer-than-expected market growth in several key countries, especially the United States, and the timing of its product launches compared with rival brands. It added that wholesale trends improved late in the quarter, which is an encouraging sign heading into the new product cycle.

Regional and Market Picture

By region, the Americas grew 4% organically, driven mainly by US managed care. EMEA (Europe, the Middle East and Africa) was flat, while Asia-Pacific rose 3%. WSA estimates that the global hearing aid market expanded by about 3% in unit volume during the quarter. The US market remained comparatively soft.

Profits Improve, but Debt Remains Heavy

Profitability moved in the right direction. EBITDA before special items climbed 12% to €119 million (about US$139 million), and the margin rose two percentage points to 19.1%. WSA credited better gross margins, operational efficiencies and cost reductions made during the previous fiscal year. Net profit for the quarter reached €24 million, up from €20 million a year earlier.

Debt is still the biggest question mark. Net interest-bearing debt stands at €2.85 billion, or about US$3.33 billion. Outgoing chief financial officer Marianne Wiinholt told Danish outlet MedWatch that leverage, measured as net debt against EBITDA, slipped to roughly 6.1 times from 6.2 times. Net interest expense over the first nine months fell to €145 million from €210 million, helped by earlier refinancing and restructuring. The company is still heavily indebted, but the trend is improving.

Signia MaX and Widex Allure AI: The Products Behind the Hopes

WSA is counting on new technology to revive its wholesale sales. Widex Allure AI RIC began rolling out in June and was scheduled to reach the US market in November. The company describes its debut as strong.

Signia MaX went on sale on August 24 in the United States, Germany and the Nordic countries, with more markets to follow later this year. Signia describes it as the first hearing aid platform to run four deep neural networks at the same time. Each network handles a different task:

  • Understanding speech

  • Analysing background noise

  • Reading the surrounding environment

  • Recognising the wearer’s own voice

WSA argues that this multi-network approach goes beyond the one-dimensional AI used in earlier devices. It believes the approach will help hearing care professionals achieve better outcomes for patients. CEO Jan Mäkelä said the launch could set new standards for what wearers expect from their hearing aids. For users, the practical promise is clearer speech in noisy places such as markets, restaurants and family gatherings, along with a more natural sound of their own voice.

Outlook: Narrower Guidance and a Contract Loss

After nine months, WSA narrowed its full-year organic growth forecast to 1–2%, down from an earlier range of 0–4%. It still expects its EBITDA margin before special items to improve by about one percentage point for the year.

A headwind is on the way, though. A large US managed care customer has decided not to renew its contract when it expires on January 1, 2027. WSA estimates the net revenue impact at €60–80 million (roughly US$70–93 million) in fiscal 2026/27. The loss does not change the outlook for the current financial year.

IPO Speculation Continues

Talk of a stock market listing has not gone away. Bloomberg reported in May that investor EQT had picked three banks to explore strategic options for WSA, including a possible Copenhagen IPO. WSA has not announced any listing or timetable.

WSA and Starkey are the only two major global hearing aid manufacturers still privately held, which is why WSA is often seen as a likely IPO candidate. Cutting debt and interest costs is widely viewed as an important step before any listing.

What This Means for Hearing Aid Buyers in India

WSA’s results offer a few practical takeaways for Indian buyers:

  1. AI is now the main battleground. Expect more hearing aids that separate speech from noise in real time, and compare these features before you buy.

  2. Availability varies by country. Signia MaX launched in only a few markets at first, and Widex Allure AI reached the US later. Ask your audiologist about expected launch dates and local service support in India.

  3. Professional fitting still matters most. Hearing aids are medical devices. A proper hearing test, correct programming and regular follow-up care affect your results as much as the technology inside.

  4. Ask about trial periods and warranty. Whichever brand you consider, check the trial period, the warranty terms and the clinic’s after-sales service.

Final Thoughts

WSA’s third quarter shows a company regaining momentum. Growth has accelerated, margins have improved and the debt burden is easing, while consumer channels offset a weak wholesale business. The next test is whether Signia MaX and Widex Allure AI can win back wholesale sales, and whether WSA can absorb the loss of a major US contract in 2027. For hearing aid users everywhere, the competition between manufacturers should bring smarter, more capable devices.

To find hearing care options near you, explore hearingaidnearme.in and speak to a qualified audiologist before choosing a device.


FAQs

1. What was WS Audiology’s organic growth in Q3 FY2025/26?
WSA reported 3% organic growth for the quarter ended June 30, up from 1% in the previous quarter.

2. How much revenue did WSA earn in the third quarter?
Revenue was €624 million, about US$729 million. Reported growth was 1% after €12 million of negative currency effects.

3. Which brands does WS Audiology own?
WSA is the parent company of Widex, Signia and Rexton.

4. What is special about Signia MaX?
Signia MaX is described as the first hearing aid platform with four deep neural networks working together. They handle speech, noise, the environment and the wearer’s own voice.

5. When did Signia MaX and Widex Allure AI launch?
Widex Allure AI RIC began rolling out in June and was scheduled for the US in November. Signia MaX launched on August 24 in the US, Germany and the Nordic countries, with more markets planned later this year.

6. Is WS Audiology planning an IPO?
Bloomberg reported that EQT hired banks to explore options, including a Copenhagen IPO. WSA has not announced a listing or a date.

7. Will these new hearing aids be available in India?
WSA has not given India-specific dates in this report. Check with a local audiologist or authorised clinic for current availability.

#WS Audiology#WSA Q3 results#Signia MaX#Widex Allure AI#Rexton#hearing aid industry news#hearing aid market growth#AI hearing aids
ShareXFacebook
Rutuja
Rutuja · Hearing Aids Expert

hearingaidnearme.in Editor

Reader Comments

Comments are reviewed by our desk before they appear. Sign in with your mobile number to join the discussion.

Web Stories

More stories ›